Home > Cashflow Statement > CORONA REMEDIES

CORONA REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Cash Flow from Operating Activities ₹229 Cr₹190 Cr₹157 Cr₹103 Cr

What is the latest Cash Flow from Operating Activities ratio of CORONA REMEDIES ?

The latest Cash Flow from Operating Activities ratio of CORONA REMEDIES is ₹229 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹229 Cr
Mar2025₹190 Cr
Mar2024₹157 Cr
Mar2023₹103 Cr

How is Cash Flow from Operating Activities of CORONA REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹229 Cr
20.47
Mar2025 ₹190 Cr
21.52
Mar2024 ₹157 Cr
52.64
Mar2023 ₹103 Cr -

Compare Cash Flow from Operating Activities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,925.1 Cr -3.7% 13.8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -1.4% 6.3% 7.8% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -1.8% 20.6% 70.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.9% 2.4% 22.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr 0.8% 12.6% 12.3% Stock Analytics
CIPLA ₹111,731.0 Cr -2.4% 4.4% -8.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-3.7%

13.8%

NA
SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses